BMI1 and colorectal cancer: The specificity of QW24 towards BMI-1 was demonstrated by the fact that normal cells expressing low levels of BMI-1 were nonresponsive while colorectal cancer cells expressing higher BMI-1 showed a dose-dependent decrease in cell viability upon treatment with QW24.